Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 5kWORD 17k
31 January 2018
E-000566-18
Question for written answer E-000566-18
to the Commission
Rule 130
Nuno Melo (PPE)

 Subject:  Fentanyl
 Answer in writing 

Fentanyl is a narcotic that is used for pain relief and anaesthesia and is the strongest opiate available for medical uses. Its strength and immediate effects may cause addiction among people taking it.

This medication is used for pain associated with cancer, among other illnesses, and it is 50 times stronger than heroin.

Use of this opiate is considered to have reached epidemic levels in the US and Canada, and there have been an unprecedented number of deaths due to overdoses. More than 20 000 deaths linked to fentanyl use were recorded in the US in 2016.

Pharmaceutical fentanyl has been used in Portugal for several years, but high levels of consumption have been seen in recent years. It is easily confused with and may be sold as heroin, since it produces similar effects.

Is the Commission aware of this situation?

What steps will it take to tighten controls on the use of fentanyl?

Original language of question: PT 
Last updated: 13 February 2018Legal notice